OSR Holdings announces Woori IO shareholders approve share exchange

OSR Holdings (OSRH) announced that the shareholders of Woori IO approved a share exchange at an Extraordinary General Meeting held at Woori IO’s headquarters in Jeonju, Korea. The approved share exchange will result in Woori IO becoming a wholly-owned subsidiary of OSR Holdings Co. Upon completion of the share exchange, Woori IO will become a wholly-owned subsidiary of OSRK, marking the final step in a sequence of corporate actions designed to integrate Woori IO fully into the OSR Group ecosystem. Woori IO is currently collaborating with Samsung Electronics on a Proof-of-Concept study in South Korea aimed at achieving Korean regulatory approval for its breakthrough noninvasive blood glucose monitoring platform. With the corporate combination now finalized, Woori IO also plans to initiate U.S. market development activities, supported by an invitation from a prestigious research university to collaborate on a U.S. FDA clinical trial for Woori IO’s technology. This collaboration is expected to serve as a foundation for advancing Woori IO’s regulatory and commercial strategy in the United States.